Impact of the eSalut Program in Hospital-at-Home (HOMeSALUT)

NCT07386275 | Completed

• 2 other identifiers: PI-22-137LT2309
• Study Type: interventional
• Target: 202
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of the study is to evaluate the impact caused by the use of the e-Salut Metro Nord App on the home hospitalization care process compared to the conventional model of care. A randomized clinical trial will be conducted with two groups: control group (patients using the conventional care model) and experimental group (patients using the app). The study population includes patients admitted to the Home Hospitalization Unit (HAD) of the Hospital Universitari Germans Trias i Pujol who agree to participate between January 2024 and April 2025. The independent variable is the use of the App. The dependent/outcome variables include: generated alerts, number of patient-initiated phone calls to professionals, App users who complete questionnaires, detected complications, unplanned in-person visits in HAD, unplanned phone visits in HAD, scheduled in-person nursing visits, scheduled medical visits, time elapsed between an alert and the professional's response, time for management and resolution of complications, unplanned visits generated by alerts, number of readmissions, patient/caregiver satisfaction, sex, age, functional assessment (Barthel Index), cognitive impairment assessment (Pfeiffer Test), anxiety and depression scales (HADS), patient activation measure (PAM-13), empowerment measure (CEPEC-47), therapeutic adherence test (ARMS-e), and health literacy (HLS-EU-Q16).

Conditions

Hospital at Home; Patients Admitted to Hospital at Home Unit

Keywords

Home Care Services, Hospital-Based; Mobile Applications; telemedicine

Outcome Measures

Primary Outcomes (1)

• Number of Participants With Hospital Readmission Within 30 Days After Discharge From Hospital-at-Home

  Number of participants who experience at least one unplanned hospital readmission within 30 days after discharge from the Hospital-at-Home program.

  30 days post discharge

Secondary Outcomes (10)

• Length of Stay in Hospital-at-Home (Days)

  From admission (day 0) to discharge (up to 30 days)

• Source of Clinical Alerts During Hospital-at-Home

  Up to 30 days after Hospital-at-Home admission

• Number of Participants With Unplanned Return to Hospital During Hospital-at-Home

  Up to 30 days after Hospital-at-Home admission

• Number of Healthcare Visits by Modality During Hospital-at-Home

  Up to 30 days after Hospital-at-Home admission

• Patient Empowerment Score Assessed by the 47-item Patient Empowerment in Chronic Conditions Questionnaire (CEPEC-47)

  Baseline and at discharge from Hospital-at-Home (mean 15 days)

Study Arms (2)

eSalut Program arm

EXPERIMENTAL

Patients admitted to home hospitalization who will use the eSalut digital platform with symptoms monitoring, alerts and communication with the care team.

Other: eSalut program arm

Control arm

OTHER

Patients admitted to home hospitalization receiving conventional care without the eSalut digital platform.

Other: Control arm

Interventions

eSalut program arm OTHER

Patients admitted to home hospitalization care with the eSalut digital platform.

Also known as: eSalut

eSalut Program arm

Control arm OTHER

Patients admitted to home hospitalization receiving conventional care without the eSalut digital platform.

Also known as: Standard care

Control arm

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• ≥18 years old
• Admitted to HAD
• Ability to read Spanish/Catalan
• Minimum digital literacy
• Smartphone/tablet with Android or iOS
• Ability to answer calls and handle the App
• Patient or caregiver can manage the device

You may not qualify if:

• Patients living in nursing homes
• Voluntary withdrawal
• Complications requiring admission unrelated to study
• Loss of patient or caregiver
• No mobile device available

Sponsors & Collaborators

• Germans Trias i Pujol Hospital: lead

Study Sites (1)

Hospitalització a Domicili. Hospital Universitari Germans Trias i Pujol

Badalona, Barcelona, 08916, Spain

Location

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health Care; Quality of Health Care; Health Services Administration; Health Care Quality, Access, and Evaluation

Study Officials

• Meritxell Davins Riu, RN, PhD

  Germans Trias i Pujol Hospital

  STUDY DIRECTOR

• Sandra Cabrera Jaime, RN, PhD

  Institut Català d'Oncologia

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Masking Details: The statistical analysis service anonymized the patients involved.
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Randomized clinical trial with two parallel groups.

Study Record Dates

• First Submitted: January 19, 2026
• First Posted: February 4, 2026
• Study Start: January 1, 2024
• Primary Completion: April 30, 2025
• Study Completion: August 15, 2025
• Last Updated: February 5, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)